LIGAND PHARMACEUTICALS INCORPORATED Net Cash Provided by (Used in) Investing Activities, Continuing Operations
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $3.94 million for the 3-month period ending 2012-03-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2012-11-14
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for the quarter ending 2012-03-31 was $3.94M.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for the quarter ending 2011-12-31 was -$2.28M, a 321.69% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for the quarter ending 2011-09-30 was -$137.00K, a 101.66% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for the quarter ending 2011-06-30 was $453.00K.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for fiscal 2011 was -$25.13M, a 272.85% decline from fiscal 2010.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for fiscal 2010 was $14.54M, a 41.30% decline from fiscal 2009.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) investing activities, continuing operations for fiscal 2009 was $24.77M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2012-03-31 | $3.94M 10-Q/A · filed 2012-11-14 | $1.67M derived: sum of 2 quarters · filed 2012-11-14 | $1.53M derived: sum of 3 quarters · filed 2012-11-14 | $1.98M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-12-31 | -$2.28M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2012-11-14 | -$2.42M derived: sum of 2 quarters · filed 2012-11-14 | -$1.96M derived: sum of 3 quarters · filed 2012-11-14 | -$25.13M 10-K/A · filed 2012-11-14 |
| 2011-09-30 | -$137.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-02-10 | $316.00K derived: sum of 2 quarters · filed 2012-02-10 | -$22.85M 10-Q/A · filed 2012-02-10 | -$21.82M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $453.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-02-10 | -$22.72M 10-Q/A · filed 2012-02-10 | -$21.69M derived: sum of 3 quarters · filed 2012-11-14 | -$13.41M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-03-31 | -$23.17M 10-Q/A · filed 2012-11-14 | -$22.14M derived: sum of 2 quarters · filed 2012-11-14 | -$13.87M derived: sum of 3 quarters · filed 2012-11-14 | |
| 2010-12-31 | $1.03M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2012-11-14 | $9.30M derived: sum of 2 quarters · filed 2012-11-14 | $14.54M 10-K/A · filed 2012-11-14 | |
| 2010-09-30 | $8.28M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-02-10 | $13.51M 10-Q/A · filed 2012-02-10 | ||
| 2010-06-30 | $5.24M 10-Q/A · filed 2012-02-10 | |||
| 2009-12-31 | $24.77M 10-K/A · filed 2012-11-14 |